Cerevast Therapeutics Obtains $10,000,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=db084ec8-6f6f-4b92-bcba-5c521df7f053
Date
12/30/2014
Company Name
Cerevast Therapeutics
Mailing Address
12277 134th Court NE Redmond, WA 98052 USA
Company Description
Cerevast Therapeutics, Inc. is a medical technology company with primary emphasis in the field of SonoLysis for the treatment acute ischemic stroke and other vascular disorders.
Website
http://www.cerevast.com
Transaction Type
Venture Equity
Transaction Amount
$10,000,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
M&A Terms
Venture Investor